We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $1.26B
1-Year Est. Return 95.39%
This Fund
S&P 500
This Quarter Est. Return
+38.95%
1 Year Est. Return
+95.39%
3 Year Est. Return
+360.87%
5 Year Est. Return
+519.82%
10 Year Est. Return
+3,025.57%
AUM
$1.26B
AUM Growth
+$303M
Cap. Flow
+$93.8M
Cap. Flow %
7.43%
Top 10 Hldgs %
35.09%
Holding
396
New
70
Increased
170
Reduced
52
Closed
74

Sector Composition

Rank Sector Weight
1 Industrials 32.12%
2 Technology 30.33%
3 Healthcare 7.92%
4 Energy 7.13%
5 Materials 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
301
PepsiCo
PEP
$183B
$222K 0.02%
1,642
-11,790
-88% -$1.76M
BCO icon
302
Brink's
BCO
$4.47B
$222K 0.02%
2,349
APH icon
303
Amphenol
APH
$193B
$219K 0.02%
+2,480
New +$179K
MOO icon
304
VanEck Agribusiness ETF
MOO
$1.15B
$219K 0.02%
+2,759
New +$224K
PPG icon
305
PPG Industries
PPG
$23.5B
$218K 0.02%
+1,800
New +$200K
UNH icon
306
UnitedHealth
UNH
$339B
$216K 0.02%
520
-1,873
-78% -$694K
NTIC icon
307
Northern Technologies International Corp
NTIC
$73.3M
$214K 0.02%
25,000
NOW icon
308
ServiceNow
NOW
$143B
$208K 0.02%
+2,100
New +$208K
UBSI icon
309
United Bankshares
UBSI
$6.44B
$208K 0.02%
+4,549
New +$199K
CWB icon
310
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.56B
$205K 0.02%
+1,901
New +$197K
SBUX icon
311
Starbucks
SBUX
$111B
$204K 0.02%
+2,000
New +$201K
NEPH icon
312
Nephros
NEPH
$47.2M
$191K 0.02%
53,479
+34,353
+180% +$112K
ELDN icon
313
Eledon Pharmaceuticals
ELDN
$218M
$142K 0.01%
+35,925
New +$131K
IDN icon
314
Intellicheck
IDN
$48M
$122K 0.01%
29,874
+4,404
+17% +$26.4K
DC icon
315
Dakota Gold
DC
$782M
$71.4K 0.01%
16,762
+604
+4% +$3.26K
AEM icon
316
Agnico Eagle Mines
AEM
$101B
-64,405
Closed -$13.1M
ALHC icon
317
Alignment Healthcare
ALHC
$1.79B
-20,440
Closed -$360K
ALK icon
318
Alaska Air
ALK
$4.5B
-6,361
Closed -$234K
ALL icon
319
Allstate
ALL
$64.1B
-19,778
Closed -$4.1M
AMAT icon
320
Applied Materials
AMAT
$334B
-1,106
Closed -$378K
AORT icon
321
Artivion
AORT
$1.2B
-7,222
Closed -$264K
APO icon
322
Apollo Global Management
APO
$74.7B
-3,781
Closed -$421K
ATEC icon
323
Alphatec Holdings
ATEC
$1.62B
-20,384
Closed -$222K
CVSA
324
Covista Inc
CVSA
$4.33B
-2,462
Closed -$284K
AVY icon
325
Avery Dennison
AVY
$13.1B
-1,178
Closed -$203K

Similar funds

Navellier & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Navellier & Associates held 396 positions worth $1.26B, up 32% from $960M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Navellier & Associates deployed $93.8M of net new capital in Q2 2026, opening 70 new positions and adding to 170 existing holdings. Its largest new stake was BrightSpring Health Services: 146,048 shares worth $10.2M.

By sector, the portfolio is most concentrated in Industrials at 32% of assets, up from 29% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Applovin, an estimated $6.91M trimmed.

  • Navellier & Associates's largest Q2 2026 buy was BrightSpring Health Services: 146,048 shares worth $10.2M.
  • Navellier & Associates added most to nVent Electric in Q2 2026, an estimated $7.24M increase.
  • Navellier & Associates's biggest Q2 2026 reduction was Applovin, cutting an estimated $6.91M.
  • Navellier & Associates fully exited Royal Caribbean in Q2 2026, selling an estimated $13.1M.
  • Navellier & Associates's ten largest holdings make up 35% of its $1.26B portfolio in Q2 2026.
  • Navellier & Associates opened 70 new positions and closed 74 in Q2 2026.
  • Navellier & Associates's portfolio value rose 32% quarter-over-quarter to $1.26B.

Based on Navellier & Associates's 13F filing for Q2 2026, filed 4 Aug 2026.